Intravitreal Vascular Endothelium Growth Factor Inhibitors for Retinal Macroaneurysms

Last year our group published the case of a foveal longstanding retinal macroaneurysm successfully treated with intravitreal ranibizumab. Few studies have also reported the safety and effectiveness of intravitreal vascular endothelium growth factor inhibitors (anti-VEGF) in the management of symptomatic retinal arterial macroaneurysms. In this commentary we make a brief review of this clinical entity, particularly of its complications and its management with emphasis on anti-VEGF therapy.